Sandbjerg Hansen M, Clemmensen I
Biochem J. 1980 Apr 1;187(1):173-80. doi: 10.1042/bj1870173.
An inhibitor of the plasma proteinase plasmin (EC 3.4.21.7) was partially purified from washed and lysed human blood platelets by (NH4)2SO4 fractionation and affinity chromatrography on Sepharose-linked purified plasminogen. The material contained none of the known plasma proteinase inhibitors when studied by crossed-immunoelectrophoresis and electroimmunoassay, but inhibited a clot-lysis-time assay and an esterolytic assay that used the synthetic substrate S-2251 (D-Val-Leu-Lys-p-nitroanilide). The inhibitory activity had the same mobility as the alpha 2-plasma proteins on preparative agarose-gel electrophoresis. Titration of the inhibitor preparation by active-site-titrated plasmin demonstrated a dissociation constant of approx. 0.1 nM. The inhibition was complete within 1 min. The inhibitor increased the mobility in agarose-gel electrophoresis of purified activator-free plasmin or 125I-labelled plasmin, as demonstrated by crossed-immunoelectrophoresis against specific immunoglobulins against plasminogen or by radioautography. The results strongly suggest the presence in platelets of a plasmin inhibitor different from the known plasma proteinase inhibitors.
通过硫酸铵分级分离以及在琼脂糖偶联纯化纤溶酶原上进行亲和层析,从洗涤并裂解的人血小板中部分纯化了血浆蛋白酶纤溶酶(EC 3.4.21.7)的一种抑制剂。通过交叉免疫电泳和免疫电泳分析发现,该物质不含任何已知的血浆蛋白酶抑制剂,但能抑制使用合成底物S-2251(D-缬氨酸-亮氨酸-赖氨酸-对硝基苯胺)的凝块溶解时间测定和酯解测定。在制备性琼脂糖凝胶电泳中,该抑制活性与α2血浆蛋白具有相同的迁移率。用活性位点滴定的纤溶酶对抑制剂制剂进行滴定,结果显示解离常数约为0.1 nM。抑制作用在1分钟内完成。通过针对纤溶酶原特异性免疫球蛋白的交叉免疫电泳或放射自显影表明,该抑制剂增加了纯化的无激活剂纤溶酶或125I标记纤溶酶在琼脂糖凝胶电泳中的迁移率。结果强烈表明血小板中存在一种不同于已知血浆蛋白酶抑制剂的纤溶酶抑制剂。